Amiodarone hydrochloride

From WikiMD's Wellness Encyclopedia

What is Amiodarone hydrochloride?[edit | edit source]


Error creating thumbnail:
AmiodaroneSVG
Error creating thumbnail:
Amiodarone-hydrochloride-xtal-packing-3x3x3-a-axis-3D-sf



What are the uses of this medicine?[edit | edit source]


How does this medicine work?[edit | edit source]

  • Amiodarone (a" mee oh' da rone) is an iodinated benzofuran derivative that is a structural analogue of thyroid hormone.
  • Amiodarone may interact with thyroid nuclear receptors, but its antiarrhythmic effects are believed to be mediated by its action in blocking membrane ion channels via perturbation of the lipid environment in the membrane bilayer.
  • Amiodarone is highly lipophilic and is concentrated in many tissues and cells, including hepatocytes in the liver.
  • It has a slow onset of action and a long but variable elimination half life (up to 6 months) and can accumulate in tissues including hepatocytes.
  • Amiodarone is highly effective in suppressing ventricular arrhythmias and in maintaining sinus rhythm in patients with atrial fibrillation.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients with:


What drug interactions can this medicine cause?[edit | edit source]


Is this medicine FDA approved?[edit | edit source]


How should this medicine be used?[edit | edit source]

Recommended dosage: The recommended starting dosing regimen is:

  • Initial Load: 150 mg in 100 mL infused over 10 minutes
  • Followed by: 1 mg/min for 6 hours
  • Followed by: 0.5 mg/min thereafter
  • For breakthrough episodes of VF or hemodynamically unstable VT, repeat the Initial Load.


Administration:

  • NEXTERONE Premixed Injection is available in GALAXY containers as a single-use, ready-to-use, iso-osmotic solution in dextrose for intravenous administration.
  • No further dilution is required.
  • Discard any unused portion after use.
  • Inspect parenteral drug products for particulate matter and discoloration prior to administration, whenever solution and container permit, solution should be clear.
  • Visually inspect the container.
  • Administer NEXTERONE, whenever possible, through a central venous catheter dedicated to that purpose.
  • Use an in-line filter during administration.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Injection, 1.5 mg/mL (150 mg/100 mL) Premixed in Dextrose
  • Injection, 1.8 mg/mL (360 mg/200 mL) Premixed in Dextrose

This medicine is available in fallowing brand namesː

  • NEXTERONE


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:


What special precautions should I follow?[edit | edit source]

  • Hypotension, the most common adverse reaction seen with intravenous amiodarone.
  • NEXTERONE causes bradycardia and AV block which may require slowing the infusion rate or discontinuing NEXTERONE. In some patients, inserting a pacemaker is required. Have a temporary pacemaker available when treating a patient predisposed to bradycardia or AV block.
  • Acute hepatocellular necrosis leading to hepatic coma, acute renal failure, and death has been associated with the administration of intravenous amiodarone. Carefully monitor patients receiving NEXTERONE for evidence of progressive hepatic injury. Consider reducing the rate of administration or withdrawing NEXTERONE if hepatic injury occurs.
  • NEXTERONE may cause a worsening of existing arrhythmias or precipitate a new arrhythmia, sometimes leading to fatal outcomes. Correct hypokalemia, hypomagnesemia or hypocalcemia whenever possible before initiating treatment with NEXTERONE. Give special attention to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or in patients receiving concomitant diuretics and laxatives.
  • There have been postmarketing reports of acute-onset (days to weeks) pulmonary injury in patients treated with intravenous amiodarone. Monitor for new respiratory symptoms and evaluate appropriately. Obtain a baseline chest X-ray and pulmonary function tests in patients who are expected to be receiving amiodarone chronically.
  • Cases of optic neuropathy and optic neuritis, usually resulting in visual impairment, have been reported in patients treated with oral amiodarone or intravenous amiodarone. Perform an ophthalmic examination if symptoms of visual impairment appear, such as changes in visual acuity and decreases in peripheral vision.
  • Nexterone inhibits peripheral conversion of throxine (T4) to triiodothyronine (T3) and may cause increased T3 levels, and increased levels of inactive reverse T3 (rT3) in clinically euthyroid patients. Monitor thyroid function prior to treatment and periodically thereafter.
  • Amiodarone can cause fetal harm when administered to a pregnant woman. Inform the patient of the potential hazard to the fetus if NEXTERONE is administered during pregnancy or if the patient becomes pregnant while taking NEXTERONE.
  • Anaphylactic/anaphylactoid reactions have been reported with intravenous amiodarone including shock (sometimes fatal), cardiac arrest, and the following manifestations: hypotension, tachycardia, hypoxia, cyanosis, rash, Stevens-Johnson syndrome, flushing, hyperhidrosis and cold sweat.
  • Infusion site phlebitis has occured in patients receiving intravenous amiodarone.


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Management of overdosage:


Can this medicine be used in pregnancy?[edit | edit source]

  • Amiodarone can cause fetal harm when administered to a pregnant woman.
  • Fetal exposure may increase the potential for adverse experiences including cardiac, thyroid, neurodevelopmental, neurological and growth effects in neonate.


Can this medicine be used in children?[edit | edit source]

  • The safety and effectiveness of amiodarone in pediatric patients have not been established.


What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredients:

  • AMIODARONE HYDROCHLORIDE

Inactive ingredients:

  • BETADEX SULFOBUTYL ETHER SODIUM
  • ANHYDROUS CITRIC ACID
  • TRISODIUM CITRATE DIHYDRATE
  • ANHYDROUS DEXTROSE
  • SODIUM HYDROXIDE
  • HYDROCHLORIC ACID
  • WATER


Who manufactures and distributes this medicine?[edit | edit source]

Deerfield, IL


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F).
  • Protect from light and excessive heat.
  • Protect from freezing.
  • Use carton to protect contents from light until used.
Amiodarone hydrochloride Resources

List of antiarrhythmic agents:





Contributors: Deepika vegiraju